CASP3 and cancer: The mitotane treatment carried out on the employed cancer cell line showed to be markedly effective in activating caspase-3 after 48 h, moderately increasing in 10-μM-treated cells in comparison to 5-μM-treated ones (Figure 2, Panel C).